Bernard A Fox

Bernard A. Fox, PhD, is the Harder Family Chair for Cancer Research, Member and Chief of the Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute; Founder and CEO of UbiVac, a clinical stage immunotherapy biotech spun out of Providence; and Adjunct Graduate Faculty, at OHSU. Dr. Fox received his Ph.D. from Wayne State University in Detroit and his postgraduate training was with Dr. Steven A. Rosenberg, at the National Cancer Institute. His research efforts are divided between basic research, moving that research into clinical trials for patients with cancer and training the next generation of investigators. Dr. Fox has authored more than 170 peer-reviewed papers and book chapters and has served as a member of review committees for the NIH, FDA, philanthropic and governmental organizations in the USA, Europe and Asia. Dr. Fox is the current Chair of the World Immunotherapy Council (WIC) and past President of the Society for Immunotherapy of Cancer (SITC). In 2015, Dr. Fox received the Visionary/Legacy Award from SITC.